liveBook · Manning

Preclinical development

As explained in Build AI Drug Discovery Pipelines

A preclinical study evaluates a drug candidate's safety and efficacy before testing in human clinical trials, typically using animals or model organisms.

Preclinical development evaluates a drug candidate’s safety and efficacy before human clinical trials, typically through testing in animals or model organisms. section 1.4.2 section 1.4.3

Preclinical evaluation supports several practical decisions:

  • Assess whether an optimized lead compound shows sufficient safety and efficacy to advance. section 1.4.2
  • Inform the candidate’s dosage, formulation, and administration for later clinical testing. section 1.4.2
  • Serve as a gate between lead optimization and clinical trials, where testing shifts to human participants. section 1.4 section 1.4.3
Figure 1.11 We can breakdown drug design into target identification and validation, hit discovery, hit-to-lead (lead identification), lead optimization, and preclinical development. Once a drug candidate has progressed to the drug development stage, it will need to pass multiple phases of clinical trials testing safety and efficacy prior to submission to and review by the FDA and launch to market.

The pipeline view places preclinical development after target identification, hit discovery, lead identification, and lead optimization, and before human clinical trials. section 1.4

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Explains subjects, safety and efficacy goals, and dosing implications without specifying experimental protocols or analysis methods.
Examples
Uses animal or model-organism studies to evaluate candidate safety and efficacy before human exposure.
What it assumes
Assumes an optimized lead compound and introduces the transition from drug discovery to clinical development.
What you can do after
Evaluate whether a candidate is ready for clinical testing and inform its dosage, formulation, and administration.
How it connects
Connects lead optimization, ADMET properties, dosage, formulation, administration, and clinical trials.

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.